CMS’ drug price negotiations are advancing, but new indications and exclusivity rules could complicate future pricing cycles. CMS gained the authority to negotiate list prices with drug manufacturers ...

President Trump just issued an executive order to rebalance the global pharmaceutical market — by tying U.S. drug prices to ...

Trump is correct. Too many drug prices are too high. How pharmacy benefit managers help inflate the prices of drugs in ...

For decades, pharmaceutical companies have shelled out big bucks to broadcasters to place ads between segments. But a pair of policies being considered by Health and Human Services Secretary Robert F.

Procuring lifesaving drugs is a daunting challenge in many low- and middle-income countries. Essential treatments are often ...

Medicaid doesn’t need price controls from other countries; it already imposes them here. Under the program’s existing “Best ...

The biopharma industry has hit a setback in its ambition to leverage President Donald Trump’s “big, beautiful bill” to amend ...

Pharmaceutical companies have little incentive to sell drugs to countries that can’t afford them. But bargaining together can ...

For Americans navigating the pharmacy counter, the price of a prescription is often just the beginning of the story. Behind ...

The FDA is launching a program to reward companies with accelerated drug review and speedy agency feedback, if their actions ...

Elon Musk took to his social media platform X to share the results of a drug test he took on June 16 amid accusations of drug ...

WASHINGTON (AP) — U.S. regulators will begin offering faster reviews to new medicines that administration officials deem as ...